| Financial Year |
March 31 2023 |
| Monetary Funds |
372,524,823.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,363,849.19 |
| Accounts Receivable |
1,272,179,587.72 |
| Advances to Suppliers |
28,573,933.86 |
| Other Receivables |
128,163,709.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
207,308,104.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
340,981.30 |
| Total Current Assets |
2,068,424,046.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,861,685.55 |
| Fixed Assetes |
122,566,067.18 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,752,993.19 |
| R&D expenses |
19,336,048.09 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,575.62 |
| Deferred Income Tax Assets |
21,425,761.78 |
| Other Non-Current Assets |
34,180,437.50 |
| Sub-Total of Non-Current Assets |
388,733,105.40 |
| Total Assets |
2,457,157,151.47 |
| Short-Term Loans |
71,943,014.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
88,691,688.70 |
| Accounts Payable |
429,300,915.13 |
| Accounts Received In Advance |
30,174.94 |
| Employee Compensation Payable |
23,965,948.27 |
| Taxes Payable |
11,459,958.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
324,566,693.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,032,390.73 |
| Other Current Liabilities |
12,324,585.86 |
| Sub-Total of Current Liabilities |
999,713,064.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,153,125.00 |
| Deferred Income Tax Liabilities |
339,524.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
63,693,087.37 |
| Total Liabilities |
1,063,406,151.62 |
| Paid-In Capital(Or Share Stock) |
595,987,425.00 |
| Capital Surplus |
199,172,934.88 |
| Surplus Reserve |
56,403,337.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
547,916,110.01 |
| Minority Stockholder's Interest |
-5,728,807.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,399,479,807.56 |
| Owner's Equity（Stockholder's Equity） |
1,393,750,999.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,457,157,151.47 |
